CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia inducible factor (HIF), today announced that John P. Butler, President and Chief Executive Officer, will present at the 2015 Morgan Stanley Global Healthcare Conference on Friday, September 18, 2015 at 10:30 a.m. Eastern Time. The conference will take place at the Grand Hyatt in New York City.
Help employers find you! Check out all the jobs and post your resume.
